Ni, Kaiyuan http://orcid.org/0000-0002-8152-6746
Lan, Guangxu http://orcid.org/0000-0002-0415-5849
Chan, Christina
Quigley, Bryan
Lu, Kuangda http://orcid.org/0000-0003-3839-3404
Aung, Theint
Guo, Nining
La Riviere, Patrick
Weichselbaum, Ralph R.
Lin, Wenbin http://orcid.org/0000-0001-7035-7759
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (U01–CA198989)
Article History
Received: 17 January 2018
Accepted: 17 May 2018
First Online: 15 June 2018
Competing interests
: W.L. is founder of RiMO Therapeutics, which licensed the nMOF Technology from the University of Chicago. R.R.W. is an advisor to RiMO Therapeutics. The remaining authors declare no competing interests.